Advancements in genetics, drug discovery and related life science technologies continue to drive new product development. Throughout the commercialization process, we provide growth capital and strategic advice to preclinical startups and well-established medical device and biopharma companies.
Our health care banking team has raised more than $750 million for public and private biotech, pharmaceutical and medical device companies.
